Affiliation:
1. Student Research Group at the I Department of Psychiatry, Psychotherapy , and Early Intervention, Medical University of Lublin , Poland
2. Department of Clinical Neuropsychiatry , Medical University of Lublin , Poland
Abstract
Abstract
Introduction: Parkinson’s disease is a neurodegenerative disease that is often accompanied by disorders such as depression, psychotic disorders, cognitive disorders, anxiety disorders, sleep disorders, impulse control disorders. The aim of the study was to review the literature and present the characteristics of neuropsychiatric disorders occurring in people suffering from Parkinson’s disease, with the specification of the above-mentioned disorders.
Material and method: The literature available on the PubMed platform from 1986 to 2022 was reviewed using the following keywords: Parkinson’s disease, depression, anxiety disorders, psychotic disorders, sleep disorders, cognitive disorders, impulse control disorders. Original studies, reviews, meta-analyzes and internet sources were analyzed.
Results: The above-mentioned neuropsychiatric disorders appear with different frequency among people suffering from Parkinson’s disease and occur at different times of its duration or even precede its onset for many years. The non-motor symptoms in the form of depressed mood, energy loss or changes in the rhythm of the day may result in a delay of appropriate therapy and thus in complications. Neuropathological changes in the course of Parkinson’s disease as well as dopaminergic drugs used in its therapy influence the development of neuropsychiatric disorders.
Conclusions: In order to avoid misdiagnosis, practitioners should use, e.g. scales intended for patients with Parkinson’s disease. To prevent the consequences of the aforementioned disease entities, methods of early diagnosis, determination of risk factors and standardization of the treatment process must be determined. Consistent care for patients with Parkinson’s disease is significant, not only in the neurological field, but also in the psychiatric one.
Reference144 articles.
1. 1. TTansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;1.10.1038/s41577-022-00684-6889508035246670
2. 2. Dorsey ER, Sherer T, Okun MS, Bloemd BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018;8(s1):S3–8.10.3233/JPD-181474631136730584159
3. 3. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–9.10.1002/mds.2180317987654
4. 4. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–45.10.1016/S1474-4422(06)70373-816488379
5. 5. RSK - Klasyfikacja ICD-10 wyniki wyszukiwania [Internet]. [cited 2022 Oct 23]. Available from: https://rsk3.ezdrowie.gov.pl/resource/structure/icd10/00CD10/10/011/url%3DaHR0cHM6Ly9yc2szLmV6ZHJvd2llLmdvdi5wbC9yZXNvdXJjZS9zdHJ1Y3R1cmUvaWNkMTAvMDBDRDEw/F06